Komori
Nagase & (8012) · RiskContinued reduction in impairment losses and exit losses

Impairment Risk Due to Deteriorating Business Profitability

First written in FY2016. 20 of 22 entries say "Materialised", first in FY2017-Q1. Latest entry: FY2026.

22entries
11years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMaterialisedFY2017-Q1 – 2026-05-072016: 320162017: 420172018: 220182019: 220192020: 320202021: 220212022: 120222023: 120232024: 020242025: 120252026: 32026
Same theme, other companies
Recognition of goodwill impairment lossA theme 34 companies write about · 34 as a headwind · 0 as a tailwind

Nagase & moved to the "Worse" side of this theme in 2016, 7 years before the typical company in this theme (2023).

The whole theme swung hardest in 2023: 7 of 13 companies on the "Worse" side.

4 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 34 companies compared. The sentences above are computed from all 34.
Full recordFilings, disclosures and news, newest first
  1. FY2026Continued reduction in impairment losses and exit lossesAnnual report

    「The loss on business withdrawal was ¥2,726 million and the impairment loss was ¥100 million for the fiscal year.」

    While the impairment loss decreased from ¥1.173 billion in the previous fiscal year to ¥100 million, the company recorded a ¥2.726 billion loss on business withdrawal related to the thin-glass processing business for glass substrates in China and other businesses.
  2. FY2025MaterialisedAnnual report

    「During the fiscal year, the company recorded an impairment loss on goodwill and intangible assets related to the Lifestyle segment of Nagase America LLC (NAM).」

    As the pharmaceutical and cosmetic ingredient sales business of NAM was no longer expected to generate the originally projected earnings, the company recorded an impairment loss of ¥1.173 billion on goodwill and other assets.
  3. FY2023MaterialisedAnnual report

    「The company recorded an impairment loss on operating assets during the fiscal year.」

    The company recorded total impairment losses of ¥2.838 billion, including ¥2.285 billion in the resin development business and ¥539 million in the 3D printing business of INTERFACIAL CONSULTANTS LLC.
  4. FY2022MaterialisedAnnual report

    「As the originally projected earnings were no longer expected, the carrying amount was reduced to the recoverable amount.」

    The company recorded an impairment loss of ¥2.974 billion in the resin-related product and manufacturing process development business and other businesses of INTERFACIAL CONSULTANTS LLC. Of this amount, ¥2.911 billion related to goodwill and other assets, and deterioration in investment profitability actually occurred.
  5. FY2021MaterialisedAnnual report

    「Total impairment loss 1,824」

    The company recorded total impairment losses of ¥1.824 billion in the Color Former manufacturing business, the polyimide film and glass lamination business in Taiwan, and other businesses, and risks arising from deteriorating business profitability continued.
  6. FY2021-Q3MaterialisedAnnual report

    「Impairment loss 29」

    The company also recorded an impairment loss of ¥29 million during the nine-month period ended the third quarter, and impairment losses continued to arise due to deteriorating business profitability and other factors.
  7. FY2021-Q2MaterialisedAnnual report

    「Impairment loss 38」

    The company also recorded an impairment loss of ¥38 million during the six-month period ended the second quarter, and impairment losses continued to arise due to deteriorating business profitability and other factors.
  8. FY2021-Q1MaterialisedAnnual report

    「Impairment loss 7」

    The company also recorded an impairment loss of ¥7 million during the three-month period ended the first quarter, and impairment losses continued to arise due to deteriorating business profitability and other factors.
  9. FY2020-Q3MaterialisedAnnual report

    「In the Electronics segment, the carrying amount of the operating assets for the thin-glass processing business for glass substrates was reduced to the recoverable amount due to deteriorating profitability. The impairment loss recognized during the nine-month period ended the third quarter was ¥1,039 million.」

    The company recorded an impairment loss of ¥1,039 million due to deteriorating profitability in the thin-glass processing business for glass substrates, up from ¥17 million in the cumulative FY2019-Q3 period.
  10. FY2019MaterialisedAnnual report

    「Total impairment loss 2,294」

    The company recorded an impairment loss of ¥2.294 billion for the fiscal year, including ¥1.999 billion on operating assets for the pharmaceutical manufacturing and sales business.
  11. FY2019-Q3MaterialisedAnnual report

    「Impairment losses ¥17 million」

    The company also recorded an impairment loss of ¥17 million during the nine-month period ended the third quarter, and impairment losses continued to arise due to deteriorating business profitability and other factors.
  12. FY2018MaterialisedAnnual report

    「Total impairment loss 847」

    In the fiscal year, the company recorded total impairment losses of ¥847 million on operating assets and other assets related to functional dyes, thin-glass processing of glass substrates in Taiwan, and resin materials processing, among other businesses.
  13. FY2018-Q3MaterialisedAnnual report

    「Impairment loss 259」

    The company recorded an impairment loss of ¥259 million during the nine-month period ended the third quarter, and impairment losses continued to arise as business profitability deteriorated.
  14. FY2018-Q2MaterialisedAnnual report

    「Impairment loss 239」

    The company recorded an impairment loss of ¥239 million during the six-month period ended the second quarter, and impairment losses continued to arise as business profitability deteriorated.
  15. FY2018-Q1MaterialisedAnnual report

    「In the Electronics segment, following the decision to withdraw from the thin-glass processing business in Taiwan, we reduced the carrying amount of the assets used in that business to their recoverable amount. The impairment loss recognized was ¥220 million for the first quarter of the consolidated fiscal year under review.」

    The company recorded an impairment loss of ¥220 million associated with the decision to withdraw from the thin-glass processing business for glass substrates in Taiwan. The impairment loss reported in the quarterly consolidated income statement was ¥225 million.
  16. FY2017MaterialisedAnnual report

    「The asset group for which an impairment loss was recognized was as follows: Operating assets; manufacture and sale of Color Former; Hokuriku region; total impairment loss: ¥1,233 million.」

    The company recorded a full-year impairment loss of ¥1.398 billion and recognized an impairment loss of ¥1.233 billion on operating assets in the Hokuriku region related to the Color Former manufacturing business.
  17. FY2017-Q3MaterialisedAnnual report

    「The impairment loss was ¥52 million.」

    The company also recorded an impairment loss of ¥52 million during the nine-month period ended the third quarter, and impairment losses continued to arise as business profitability deteriorated.
  18. FY2017-Q2MaterialisedAnnual report

    「The impairment loss was ¥38 million.」

    The company also recorded an impairment loss during the six-month period ended the second quarter.
  19. FY2017-Q1MaterialisedAnnual report

    「The impairment loss was ¥10 million.」

    The company also recorded an impairment loss of ¥10 million in the first quarter.
  20. FY2016First statedAnnual report

    「The Group holds fixed assets, including operating assets and goodwill at its manufacturing subsidiaries, and may incur impairment losses if the value of these assets declines.」

    The company recorded an impairment loss of ¥2.756 billion for the period and explained that the goodwill associated with industrial adhesives and other businesses was no longer expected to generate the originally projected earnings.
Moved together

"Changes in Trends Across the Chemical Industry" moved the same way as this thread, in the same document, in 9 of its 22 moves.

986542★123456
  1. ★This thread
  2. 1Changes in Trends Across the Chemical Industry9×
  3. 2Translation Risk from Foreign-Currency Transactions and Overseas Financial Statements8×
  4. 3Share Price Volatility Risk Relating to Marketable Equity Securities and Pension Assets6×
  5. 4Supply Chain Disruption and Factory Damage Risk5×
  6. 5Price Volatility of Petrochemical Products and Grain-Derived Raw Materials4×
  7. 6Contributing to a Safe and Secure Society through “Discover, Nurture and Expand”2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Nagase & yet. It last moved in the Financial results presentation of 2026-05-07: "Materialised".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Impairment Risk Due to Deteriorating Business Profitability | NAGASE & CO.,LTD. (8012) | Komori